Deere & Company’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Deere & Company’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-38,450	Closed	-$652K	–	1150
2014 Q4	$652K	Sell	38,450 -16,327	-30%	-$230K	0.04%	527
2014 Q3	$653K	Buy	54,777 +7,427	+16%	+$50.7K	0.04%	515
2014 Q2	$267K	Hold	47,350	–	–	0.01%	760
2014 Q1	$174K	Buy	+47,350	New	+$180K	0.01%	880

Deere & Company's AVNR Position: Q1 2015 in Review

Deere & Company sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 38,450 shares — an estimated $652K sold.

Deere & Company first reported a position in AVNR in Q1 2014 and held it in 4 quarters. The position peaked at $653K in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Deere & Company reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Deere & Company sold 38,450 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $652K.
Deere & Company first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q1 2014 and held it in 4 quarters.
Deere & Company's AVANIR PHARMACEUTICALS, INC CL A position peaked at $653K in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Deere & Company's 13F filing for Q1 2015, filed 13 May 2015.